Literature DB >> 30982091

CKLF1 Aggravates Focal Cerebral Ischemia Injury at Early Stage Partly by Modulating Microglia/Macrophage Toward M1 Polarization Through CCR4.

Chen Chen1, Shi-Feng Chu1, Qi-Di Ai2, Zhao Zhang1, Fei-Fei Guan3, Sha-Sha Wang4, Yi-Xiao Dong5, Jie Zhu6, Wen-Xuan Jian7, Nai-Hong Chen8,9.   

Abstract

CKLF1 is a chemokine with increased expression in ischemic brain, and targeting CKLF1 has shown therapeutic effects in cerebral ischemia model. Microglia/macrophage polarization is a mechanism involved in poststroke injury expansion. Considering the quick and obvious response of CKLF1 and expeditious evolution of stroke lesions, we focused on the effects of CKLF1 on microglial/macrophage polarization at early stage of ischemic stroke (IS). The present study is to investigate the CKLF1-mediated expression of microglia/macrophage phenotypes in vitro and in vivo, discussing the involved pathway. Primary microglia culture was used in vitro, and mice transient middle cerebral artery occlusion (MCAO) model was adopted to mimic IS. CKLF1 was added to the primary microglia for 24 h, and we found that CKLF1 modulated primary microglia skew toward M1 phenotype. In mice transient IS model, CKLF1 was stereotactically microinjected to the lateral ventricle of ischemic hemisphere. CKLF1 aggravated ischemic injury, accompanied by promoting microglia/macrophage toward M1 phenotypic polarization. Increased expression of pro-inflammatory cytokines and decreased expression of anti-inflammatory cytokines were observed in mice subjected to cerebral ischemia and administrated with CKLF1. CKLF1-/- mice were used to confirm the effects of CKLF1. CKLF1-/- mice showed lighter cerebral damage and decreased M1 phenotype of microglia/macrophage compared with the WT control subjected to cerebral ischemia. Moreover, NF-κB activation enhancement was detected in CKLF1 treatment group. Our results demonstrated that CKLF1 is an important mediator that skewing microglia/macrophage toward M1 phenotype at early stage of cerebral ischemic injury, which further deteriorates followed inflammatory response, contributing to early expansion of cerebral ischemia injury. Targeting CKLF1 may be a novel way for IS therapy.

Entities:  

Keywords:  CCR4; CKLF1; Ischemic stroke; Microglia/macrophage; Polarization

Mesh:

Substances:

Year:  2019        PMID: 30982091     DOI: 10.1007/s10571-019-00669-5

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  11 in total

1.  Chemokine-like factor 1: A promising therapeutic target in human diseases.

Authors:  Xiaopeng Cai; Jingwen Deng; Qianqian Ming; Huiqiang Cai; Zhi Chen
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-26

2.  Activated Microglia Exosomes Mediated miR-383-3p Promotes Neuronal Necroptosis Through Inhibiting ATF4 Expression in Intracerebral Hemorrhage.

Authors:  Min Wei; Chen Li; Zhengcun Yan; Zhengwei Hu; Lun Dong; Jun Zhang; Xingdong Wang; Yuping Li; Hengzhu Zhang
Journal:  Neurochem Res       Date:  2021-02-16       Impact factor: 3.996

3.  Neuronal chemokine-like-factor 1 (CKLF1) up-regulation promotes M1 polarization of microglia in rat brain after stroke.

Authors:  Xin Zhou; Ya-Ni Zhang; Fang-Fang Li; Zhao Zhang; Li-Yuan Cui; Hong-Yuan He; Xu Yan; Wen-Bin He; Hong-Shuo Sun; Zhong-Ping Feng; Shi-Feng Chu; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2021-08-12       Impact factor: 7.169

4.  Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington's disease via suppressing MAPKs and NF-κB pathways in the striatum.

Authors:  Xiong Yang; Shi-Feng Chu; Zhen-Zhen Wang; Fang-Fang Li; Yu-He Yuan; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2020-11-19       Impact factor: 7.169

5.  CCR4 and CCR5 Involvement in Monocyte-Derived Macrophage Migration in Neuroinflammation.

Authors:  Jong Youl Kim; Jiwon Kim; Meiying Huang; Renée Kosonen; Jong Eun Lee
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

Review 6.  Immunoreactive Cells After Cerebral Ischemia.

Authors:  Yijie Wang; John H Zhang; Jifang Sheng; Anwen Shao
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

Review 7.  Microglial Polarization: Novel Therapeutic Strategy against Ischemic Stroke.

Authors:  Yimeng Xue; Ding Nie; Lin-Jian Wang; Han-Cheng Qiu; Long Ma; Ming-Xin Dong; Wen-Jun Tu; Jizong Zhao
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

8.  Aminoacyl transfer ribonucleic acid synthetase complex-interacting multifunctional protein 1 induces microglial activation and M1 polarization via the mitogen-activated protein kinase/nuclear factor-kappa B signaling pathway.

Authors:  Yebin Oh; Hak-Jun Jung; Seungwon Hong; Yerim Cho; Jiyeong Park; Daeho Cho; Tae Sung Kim
Journal:  Front Cell Neurosci       Date:  2022-09-07       Impact factor: 6.147

9.  Pyk2 inhibition attenuates hypoxic-ischemic brain injury in neonatal mice.

Authors:  Jie Zhu; Shi-Feng Chu; Ye Peng; Dan-Dan Liu; Chen Chen; Wen-Xuan Jian; Hong-Shuo Sun; Zhong-Ping Feng; Zhao Zhang; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2021-07-05       Impact factor: 6.150

Review 10.  Chemotherapeutic Drug-Regulated Cytokines Might Influence Therapeutic Efficacy in HCC.

Authors:  Chun-I Wang; Pei-Ming Chu; Yi-Li Chen; Yang-Hsiang Lin; Cheng-Yi Chen
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.